Literature DB >> 19995851

In pursuit of the high-resolution structure of nicotinic acetylcholine receptors.

Lin Chen1.   

Abstract

The nicotinic acetylcholine receptor (nAChR) has been studied extensively for well over four decades because of its important physiological roles and medical relevance. A large body of data from biochemical and biophysical studies are now available. The structural information, which is needed to integrate existing data to address the mechanism and function of nAChRs, started to emerge in recent years. Structural studies of acetylcholine binding proteins (AChBPs) have greatly facilitated the study of nAChRs. The recently determined crystal structures of the prokaryotic homologues of nAChRs will probably have similar impact over time. However, a direct structural model of nAChRs at high resolution will be important for mechanistic studies and drug development. Here we will review some of the recent efforts in this area and use the high-resolution structure of the extracellular domains of nAChR alpha1 to illustrate the potential insights one may gain at higher resolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995851      PMCID: PMC2828130          DOI: 10.1113/jphysiol.2009.184085

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

1.  Mapping the conformational wave of acetylcholine receptor channel gating.

Authors:  C Grosman; M Zhou; A Auerbach
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

Review 2.  Emerging structure of the nicotinic acetylcholine receptors.

Authors:  Arthur Karlin
Journal:  Nat Rev Neurosci       Date:  2002-02       Impact factor: 34.870

3.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 4.  A touching picture of nicotinic binding.

Authors:  Arthur Karlin
Journal:  Neuron       Date:  2004-03-25       Impact factor: 17.173

5.  Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Authors:  Jie Luo; Palmer Taylor; Mario Losen; Marc H de Baets; G Diane Shelton; Jon Lindstrom
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

6.  Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit.

Authors:  Yun Yao; Junmei Wang; Nitnara Viroonchatapan; Avraham Samson; Jordan Chill; Elizabeth Rothe; Jacob Anglister; Zuo-Zhong Wang
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

7.  Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding.

Authors:  Loukia Psaridi-Linardaki; Avgi Mamalaki; Michael Remoundos; Socrates J Tzartos
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

8.  Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.

Authors:  T Tsouloufis; A Mamalaki; M Remoundos; S J Tzartos
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

9.  Structure and gating mechanism of the acetylcholine receptor pore.

Authors:  Atsuo Miyazawa; Yoshinori Fujiyoshi; Nigel Unwin
Journal:  Nature       Date:  2003-06-26       Impact factor: 49.962

10.  Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.

Authors:  Patrick H N Celie; Sarah E van Rossum-Fikkert; Willem J van Dijk; Katjusa Brejc; August B Smit; Titia K Sixma
Journal:  Neuron       Date:  2004-03-25       Impact factor: 17.173

View more
  8 in total

1.  N-glycosylation in regulation of the nervous system.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Adv Neurobiol       Date:  2014

2.  Advances and hold-ups in the study of structure, function and regulation of Cys-loop ligand-gated ion channels and receptors.

Authors:  Jerrel Yakel
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

3.  Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain.

Authors:  Marios Zouridakis; Petros Giastas; Eleftherios Zarkadas; Dafni Chroni-Tzartou; Piotr Bregestovski; Socrates J Tzartos
Journal:  Nat Struct Mol Biol       Date:  2014-10-05       Impact factor: 15.369

4.  Assessment of the functionality and stability of detergent purified nAChR from Torpedo using lipidic matrixes and macroscopic electrophysiology.

Authors:  Luis F Padilla-Morales; José O Colón-Sáez; Joel E González-Nieves; Orestes Quesada-González; José A Lasalde-Dominicci
Journal:  Biochim Biophys Acta       Date:  2015-10-08

Review 5.  The role of protein N-glycosylation in neural transmission.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Glycobiology       Date:  2014-03-18       Impact factor: 4.313

6.  Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues.

Authors:  Melanie Abongwa; Samuel K Buxton; Elise Courtot; Claude L Charvet; Cédric Neveu; Ciaran J McCoy; Saurabh Verma; Alan P Robertson; Richard J Martin
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

7.  Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.

Authors:  Kaori Noridomi; Go Watanabe; Melissa N Hansen; Gye Won Han; Lin Chen
Journal:  Elife       Date:  2017-04-25       Impact factor: 8.140

Review 8.  Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.

Authors:  Wuyi Liu; Ming D Li
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.